MEDIA ALERT: MAC AIDS Fund Survey Exposes Startlingly ‘No-Risk’ Attitude Amongst UK Women – 73 Percent Admit to Never Being Tested for HIV/AIDS

LONDON, March 1, 2010 – A new UK study from the MAC AIDS Fund (MAF), the philanthropic arm of
Estee Lauder-owned (NYSE: EL) MAC Cosmetics, shockingly reveals prevalent
risky behavior amongst British women due to significant gaps in HIV awareness
and education. Almost three quarters (73 percent) of women in the UK admit
they've never been tested for [...]

Shire Supports Rare Disease Day 2010

CAMBRIDGE, Massachusetts and BASINGSTOKE, England, March 1, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, today announced it will actively support Rare
Disease Day across the world by generating media coverage in many countries
to raise awareness and understanding of rare diseases.

Rare Disease Day seeks to call attention [...]

Elsevier Addresses Today’s Healthcare Information Crisis With a Renewed Focus on Improving Quality and Efficiency

At HIMSS 2010, Elsevier's Top Experts Will Present Strategic and Tactical Solutions to Help Providers Improve Healthcare Quality, Achieve Meaningful Use

PHILADELPHIA, March 1, 2010 – Advancing healthcare quality to help improve patient outcomes
and economic efficiency continues to be a primary focus in 2010 for Elsevier,
the leading publisher of scientific, technical and medical information.
During HIMSS [...]

Gold Standard/Elsevier Launches Clinical Pharmacology Mobile

Reference Tool Puts Real-Time, Evidence-Based Drug Information Onto Mobile Devices at the Point of Care

TAMPA, Florida, March 1, 2010 – Gold Standard/Elsevier (www.goldstandard.com), a
leading provider of drug decision support announced today the availability of
Clinical Pharmacology Mobile, a mobile device-optimized web site offering
users access to the features and functions of Clinical Pharmacology, an
award-winning electronic drug [...]

First Personal Injury Applauds HSE Campaign

MANCHESTER, England, March 1, 2010 – Accident Claims(www.firstpersonalinjury.co.uk/) Solicitors, First
Personal Injury has praised the latest phase of the Health and Safety
Executive's Shattered Lives safety campaign.

The latest phase of the campaign aims to raise awareness of the potential
dangers of trips and falls in the workplace and features some graphic and
hard hitting [...]

Technological Advances Provide a Fillip to the European IV Therapy and Enteral Nutrition Devices Market, Notes Frost & Sullivan

LONDON, March 1, 2010 – The European intravenous (IV) therapy and enteral nutrition devices
market currently offers a highly dynamic and lucrative environment. Advances
in pharmacology and a wider range of blood products have substantially
increased the number of possible drug therapies, which can be used with IV
therapy devices. At the same time, developments in biotechnology are [...]

Catholic Health Initiatives Selects Six of Elsevier’s Online Solutions To Enhance Quality Clinical Decision-Making

Mosby's Nursing Suite and Clinical Pharmacology are now the Primary Decision-support Resources at CHI's 75 Hospitals Across 19 States

PHILADELPHIA, Pennsylvania, March 1, 2010 – Elsevier (www.elsevier.com), a world leader in health
care and medical publishing and online solutions, today announced that
Denver-based Catholic Health Initiatives (www.catholichealthinit.org/
) (CHI), the second-largest faith-based health care system in the nation,
will [...]

Bayer Introduces CONTOUR(R) USB – Innovative Plug and Play Technology That Puts People With Diabetes in the Driving Seat

NEWBURY, England, March 1, 2010 – Today Bayer Diabetes Care launch their new CONTOUR(R) USB
blood glucose meter in the UK and Ireland. Bayer's CONTOUR(R) USB is the
first blood glucose meter with cutting edge 'plug and play' technology and a
built-in USB that inserts directly into a computer. This innovative meter
provides users with instant access to [...]

Health Robotics’ i.v.STATION Robot Proven to be Almost Four Times Faster Than Intelligent Hospital Systems’ RIVA

BOZEN, SUD-TIROL, Italy, March 1, 2010 – Health Robotics today announced the public evaluation of video speed
tests between i.v.STATION and RIVA sterile compounding robots, based on each
companies' public video testimonials at their respective web sites of an
identical powder reconstitution (80 ml) and size/dose of syringe (10cc).
Founded on this side-by-side comparison and other publicly available
information, [...]

CRF Health Reports Record Growth and Earnings

LANSDALE, Pennsylvania, March 1, 2010 – CRF Health, a leading provider of electronic Patient Reported Outcomes
(ePRO) for the life sciences industry, announced record-setting growth and
earnings for 2009. Client commitments grew by 65% and resulted in
record-setting revenue, earnings and backlog. Sales came from both new and
existing clients and the company continues to gain market share. [...]

Torchmark Corporation Elects New Director

MCKINNEY, Texas, March 1, 2010 – Torchmark Corporation (NYSE: TMK) announced that Darren M. Rebelez,
Executive Vice President and Chief Operating Officer of 7-Eleven, Inc., was
elected to its Board of Directors on February 25, 2010. A California native
and Texas resident, Mr. Rebelez holds a B.S. degree in General Engineering
from the United States Military Academy in [...]

Torchmark Corporation Declares Dividend and Resumes Stock Repurchases

MCKINNEY, Texas, March 1, 2010 – Torchmark Corporation (NYSE: TMK) announced that its Board of Directors
has declared a quarterly dividend of US$.15 per share on all of the
outstanding common stock of the Company held of record as of the close of
business of the Company's transfer agent on April 2, 2010. The dividend will
be paid [...]

Teva UK Limited Launches Generic Losartan

CASTLEFORD, England, March 2, 2010 – We are pleased to announce the launch of losartan potassium film-coated
tablets available in 25mg, 50mg and 100mg strengths, in packs of 28. Losartan
is indicated for the treatment of essential hypertension(1).

It is a generic version of Cozaar(R) Black Triangle Drug (losartan)
from MSD and is available [...]

AmpVacs a Broadly Protective Synthetic Influenza A Vaccine

AMSTERDAM, March 2, 2010 – Sanquin Blood Supply Foundation, the Netherlands Cancer Institute, and
the Netherlands Vaccine Institute announce today the launch of their joint
AmpVacs project aiming at the development of a broadly protective synthetic
influenza A vaccine component that in combination with classical
antibody-stimulating vaccines will induce protection against future influenza
A threats.

The [...]

Twenty-Five Years of HIV Blood Testing Helped to Positively Transform Global Health Crisis

ABBOTT PARK, Illinois, March 2, 2010 – Imagine delaying a life-saving surgery or being afraid to receive or
donate blood for fear of contracting HIV (www.who.int/hiv/en/). It
seems unbelievable today, but twenty-five years ago, this was the reality as
the world struggled to keep the deadly virus out of the blood supply.

(Photo: www.newscom.com/cgi-bin/prnh/20100302/CG63179-a)
[...]

ReportsandReports : The Gastrointestinal Market Outlook to 2014: Market Dynamics, Competitive Landscape, Emerging Therapies

DALLAS, March 2, 2010 – ReportsandReports announce to have The Gastrointestinal Market Outlook to
2014: (
www.reportsandreports.com/market-reports/the-gastrointestinal-market-o
utlook-to-2014-market-dynamics-com/) Market dynamics, competitive landscape,
emerging therapies Market Research Report in its store.

(Due to the length of this URL, it may be necessary to copy and paste
this hyperlink into your Internet browser's URL address field. Remove the
space [...]

European Authorities Accept Voclosporin for Regulatory Review

Trades on Toronto Stock Exchange – (TSX: ISA)
EDMONTON, Canada, March 2, 2010 – Isotechnika Pharma Inc. (TSX: ISA) today announced that the European
Medicines Agency (EMA) has validated the Marketing Authorization Application
(MAA) filed by its partner, Lux Biosciences, Inc., for voclosporin.
Following validation of the MAA, the dossier is distributed to members of
the Committee for Medicinal [...]

New Evidence Adds to Concerns of Widespread Asbestos Exposure in Schools

LONDON, March 2, 2010 – Shocking new data from a previously unpublished government report was
unveiled today by Clinica MedTech Intelligence, indicating that the problem
of asbestos exposure in schools is worse than previously publicised.

New evidence emerged last week of the suspected widespread failure of UK
schools to observe asbestos safety regulations, heightening [...]

Costly Legacy of the Recession: Employers Risk Mass Exodus of Neglected Staff

ANDOVER, England, March 4, 2010 – A recent survey of the nation's employees carried out by
healthcare provider Simplyhealth has revealed that one in two UK staff say
their mental and physical wellbeing was ignored by their employer during the
economic downturn. A similar number – over 45% – also say that they will
start looking for a [...]

Making a Positive Response to the Closure of the AstraZeneca Charnwood Research Site

NOTTINGHAM, England, March 3, 2010 – Chief Executive of BioCity Nottingham, Dr Glenn Crocker is available to
comment into how the East Midlands might respond to the closure of the
AstraZeneca Charnwood Research Site and offer some positive possibilities in
the aftermath of this bleak event.

In particular Dr Crocker can:

[...]

Stemgent Invests US$4.5 Million, Announces Formation of Ubiquigent, a New UK-Listed Biotechnology Company Based in Dundee, Scotland

New Venture co-founded with Professor Sir Philip Cohen to Focus on the Ubiquitin Proteasome Pathway, a Key Cell Signalling System with Significant Drug Discovery Potential

BOSTON and SAN DIEGO, March 3, 2010 – Stemgent, Inc., a biotechnology company based in San Diego, California,
and Boston, Massachusetts, USA, announced today the formation of Ubiquigent
Ltd, a new biotechnology [...]

Kantar Health Names Ceri Thomas Head of Global Marketing

NEW YORK, March 3, 2010 – Kantar Health, a leading healthcare-focused global consultancy and
marketing insights company, has appointed Ceri Thomas as Head of Global
Marketing. In this role, he will develop and implement Kantar Health's global
marketing strategies. Mr. Thomas is based in Kantar Health's London-area
office.

"Ceri's global experience and perspective, combined with [...]

Further Wins Two Branding Awards at the Transform Awards 2010

LONDON, March 3, 2010 – Further were winners at the Transform Awards 2010 with a Gold for best
rebrand in the public sector for King's Health Partners and Bronze for best
rebrand of a service for Cinven.

Further's work with King's College London and the three NHS Foundation
Trusts of Guy's and St Thomas', [...]

Sensitech’s Groundbreaking TempTale(R)4 USB Dry Ice Temperature Monitor Provides Fast, Simple, Efficient Cold Chain Visibility

BEVERLY, Massachusetts, March 3, 2010 – Sensitech Inc.'s new TempTale(R)4 USB Dry Ice temperature monitor is the
first on the market to offer a self-contained, probeless temperature monitor
with automatic Adobe(R) PDF file generation capabilities and a USB
communications interface. Sensitech, the global leader in cold-chain
visibility solutions, is a wholly owned subsidiary of Carrier Corp., a
business unit [...]

Long Waits for Radiotherapy Linked to Increased Recurrence of Breast Cancer

Professor Karol Sikora Comments on New Research Published in BMJ 3.03.10
LONDON, March 3, 2010 – A large US study published today shows that there is a strong
correlation between delay in accessing radiotherapy for breast cancer and the
incidence of local recurrence. A steady rise in recurrence developed when the
time from surgery to radiotherapy exceeded 8 [...]

Women for Positive Action: an International Partnership Dedicated to Enhancing the Lives of Women Living with HIV

LONDON, March 4, 2010 – To mark International Women's Day (March 8, 2010) Women for Positive
Action are launching a series of tools to raise awareness of the challenges
facing women living with HIV/AIDS today. Women for Positive Action (WFPA) is
led by a broad coalition of healthcare professionals, women living with HIV
and community representatives from Europe, [...]

Medtronic Named Among World’s Most Innovative Companies by MIT Technology Review

Company Recognized for Ground-Breaking Work in the Field of Deep Brain Stimulation

MINNEAPOLIS, March 4, 2010 – Medtronic, Inc. (NYSE: MDT) today announced that it has been selected as
one of Massachusetts Institute of Technology (MIT) Technology Review's 50
most innovative companies. Known as TR50, the first annual list includes
companies that Technology Review believes have demonstrated superiority [...]

Atacama Labs Enters Into Partnership With Excella Gmbh, Which is Part of Fareva Holding, a Top 10 Global Contract Manufacturer

A Finnish Company ATACAMA LABS OY and a German Based EXCELLA GmbH (Fareva Holding SA) Have Signed a Contract Manufacturing Agreement to Jointly Market and Sell PDG Granule and Tablet Manufacturing Services for the Pharmaceutical Industry

HELSINKI, Finland, March 4, 2010 – Atacama Labs Oy has developed an innovative oral drug delivery technology
(called 'pneumatic dry [...]

Genzyme Corporation’s Generous Benefaction to Enable the Creation of a Key Clinical Academic Post for Multiple Sclerosis, Neuroimmunological Diseases

Expands Commitment to University of Cambridge Community
CAMBRIDGE, England, March 4, 2010 – The University of Cambridge announced today that Genzyme Corporation, a
diversified, global biotechnology company with significant operations in
Cambridge and across the United Kingdom, has made a generous benefaction to
endow a key clinical academic post at the university dedicated to the
advancement of fundamental and [...]

First Breast Cancer Patients in Europe to be Treated With Revolutionary Therapy System

VEENENDAAL, The Netherlands, March 4, 2010 – Today the first patients in Europe are to receive treatment for breast
cancer using a revolutionary system called AccuBoost. The Italian hospital
where the patients are being treated is using the technology to pinpoint the
tumour bed and treat it whilst still protecting the patient's healthy
surrounding tissue and organs. This [...]

Isotechnika Pharma Receives National Research Council IRAP Funding for NICAM Program

EDMONTON, Canada, March 4, 2010 – Isotechnika Pharma Inc. (TSX: ISA) today announced that it has received
funding approval from the National Research Council's Industrial Research
Assistance Program (IRAP) for its Non-Immunosuppressive Cyclosporin Analog
Molecules (NICAM) program. The grant of CDN$237,069 will support the
development progress of the NICAM program which is part of an emerging
therapeutic field that [...]